FIORUCCI, Stefano
 Distribuzione geografica
Continente #
EU - Europa 167
NA - Nord America 26
AS - Asia 11
OC - Oceania 1
Totale 205
Nazione #
IT - Italia 118
US - Stati Uniti d'America 22
IE - Irlanda 19
DE - Germania 9
IN - India 6
CA - Canada 4
GR - Grecia 4
UA - Ucraina 4
NL - Olanda 3
CZ - Repubblica Ceca 2
GB - Regno Unito 2
HK - Hong Kong 2
AT - Austria 1
CH - Svizzera 1
ES - Italia 1
FI - Finlandia 1
JP - Giappone 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SE - Svezia 1
TR - Turchia 1
VN - Vietnam 1
Totale 205
Città #
Perugia 84
Dublin 19
Corciano 5
Ashburn 4
Council Bluffs 4
Milan 4
Athens 3
Civitanova Marche 3
Toronto 3
Zogno 3
Bad Sassendorf 2
Hamburg 2
Nuremberg 2
Turin 2
Vaiano 2
Adapazarı 1
Barcelona 1
Bedford 1
Bologna 1
Brooklyn 1
Cagliari 1
Central 1
Concord 1
Cosenza 1
Dallas 1
Delhi 1
Faringdon 1
Forest Park 1
Frankfurt am Main 1
Freiberg 1
Hanoi 1
Helsinki 1
Hohen Neuendorf 1
Kharkiv 1
Lausanne 1
Los Angeles 1
Lucknow 1
Madison 1
New Berlin 1
New Delhi 1
Orangeville 1
Oslo 1
Raamsdonksveer 1
Saint Paul 1
Stockholm 1
Tivoli 1
Tokyo 1
Veroia 1
Vienna 1
Totale 176
Nome #
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling, file d40016d1-f93a-42b8-99ae-55d579c008ed 39
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions, file e3aa200f-0ab6-ebae-e053-6605fe0a5b79 23
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis, file e3aa2010-2b06-ebae-e053-6605fe0a5b79 22
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies, file e3aa200d-45f0-ebae-e053-6605fe0a5b79 14
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury, file 89ea69f7-f020-4cdc-b6fe-c2ac9adacc1c 13
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines, file e3aa200f-1a7f-ebae-e053-6605fe0a5b79 13
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties, file e3aa2010-33c2-ebae-e053-6605fe0a5b79 13
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis, file e3aa200f-207d-ebae-e053-6605fe0a5b79 8
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease, file e3aa2010-0ca7-ebae-e053-6605fe0a5b79 7
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury, file e3aa2010-d98c-ebae-e053-6605fe0a5b79 6
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice., file e3aa200e-945b-ebae-e053-6605fe0a5b79 4
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma, file e3aa200e-9965-ebae-e053-6605fe0a5b79 4
Synthesis and characterization of well-defined poly(2-deoxy-2-methacrylamido-D-glucose) and its biopotential block copolymers via RAFT and ROP polymerization, file e3aa200e-306b-ebae-e053-6605fe0a5b79 2
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS, file e3aa200e-e3a3-ebae-e053-6605fe0a5b79 2
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis, file e3aa200f-0aba-ebae-e053-6605fe0a5b79 2
Nanotraps with biomimetic surface as decoys for chemokines, file e3aa200f-1bbb-ebae-e053-6605fe0a5b79 2
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases, file e3aa200f-1c22-ebae-e053-6605fe0a5b79 2
Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis, file e3aa200f-207b-ebae-e053-6605fe0a5b79 2
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis, file e3aa2011-0d36-ebae-e053-6605fe0a5b79 2
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease, file 4c40f958-1bf6-4dcc-987f-ab2e7b32e123 1
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma, file 6b1bbb5d-ee70-4fe9-9878-e120fdfb78cf 1
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma, file cf651b16-583a-4138-bd8b-2f7bb76e8a62 1
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists, file e3aa200d-43b9-ebae-e053-6605fe0a5b79 1
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells, file e3aa200d-f4ae-ebae-e053-6605fe0a5b79 1
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite, file e3aa200e-3069-ebae-e053-6605fe0a5b79 1
Farnesoid X receptor modulators 2014-present: a patent review, file e3aa200e-6210-ebae-e053-6605fe0a5b79 1
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis, file e3aa200e-fd34-ebae-e053-6605fe0a5b79 1
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders, file e3aa200f-0027-ebae-e053-6605fe0a5b79 1
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand, file e3aa200f-1a01-ebae-e053-6605fe0a5b79 1
Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders, file e3aa200f-1a7a-ebae-e053-6605fe0a5b79 1
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1, file e3aa200f-3fb0-ebae-e053-6605fe0a5b79 1
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy, file e3aa200f-58e4-ebae-e053-6605fe0a5b79 1
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain, file e3aa200f-7244-ebae-e053-6605fe0a5b79 1
Bile Acid Signaling in Inflammatory Bowel Diseases, file e3aa200f-8b98-ebae-e053-6605fe0a5b79 1
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH), file e3aa200f-9ff4-ebae-e053-6605fe0a5b79 1
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH, file e3aa200f-eade-ebae-e053-6605fe0a5b79 1
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction, file e3aa200f-f374-ebae-e053-6605fe0a5b79 1
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential, file e3aa200f-f451-ebae-e053-6605fe0a5b79 1
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling, file e3aa2010-2390-ebae-e053-6605fe0a5b79 1
Bile Acids Activated Receptors in Inflammatory Bowel Disease, file e3aa2010-2ae8-ebae-e053-6605fe0a5b79 1
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity, file e3aa2010-33c0-ebae-e053-6605fe0a5b79 1
Bile acids and their receptors in metabolic disorders, file e3aa2010-33cb-ebae-e053-6605fe0a5b79 1
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation, file e3aa2010-743f-ebae-e053-6605fe0a5b79 1
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities, file e3aa2010-c6a3-ebae-e053-6605fe0a5b79 1
Totale 205
Categoria #
all - tutte 688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 2 6 0 0 0 0 0 0 2 0 0
2020/20214 1 0 0 0 2 0 0 0 1 0 0 0
2021/202271 0 0 0 0 0 0 0 0 0 22 21 28
2022/2023114 0 2 26 4 5 11 18 7 29 2 9 1
2023/20245 0 0 1 0 3 0 1 0 0 0 0 0
Totale 205